Farmers and Merchants Bancshares Reports $5.7 Million Nine-Month Profit

Farmers and Merchants Bancshares reported a nine-month net income of $5.746 million, or $1.76 per diluted share, up from $4.069 million a year earlier. Third-quarter net income rose to $2.025 million. Net interest income increased to $20.719 million, with no provision for credit losses. Assets and loans grew, while deposits and borrowings declined. Management highlighted investments in staffing and customer service.

Original reporting
Published Oct 22, 2026, 1:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 1:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Farmers and Merchants Bancshares Reports $5.7 Million Nine-Month Profit — source image
Decision brief

The 30-second read

$FMFGBullishLow
01

Why it matters

The earnings beat and clean credit profile provide a modest bullish catalyst for the stock, though the scale is small.

02

Market read

Small‑cap regional bank earnings release with modest upside potential; limited broader market effect.

03

What to watch

Deposit decline and modest asset growth could pressure margins if rates compress.

Relevance 5/10Novelty 6/10Timing: post‑market today

Background

Farmers & Merchants Bancshares filed an 8‑K reporting its nine‑month results, highlighting earnings growth and a zero provision for credit losses.

Company-level read

Ticker impact

$FMFGBullishHigh confidence
Context

Farmers & Merchants Bancshares reported nine‑month profit of $5.746 M, up from $4.069 M a year earlier, with no credit‑loss provision.

Expected impact

likely modest upside as investors price in higher earnings and zero credit loss provision

Evidence & confidence

Profit rose ~41% YoY and the absence of a credit‑loss provision signals stronger asset quality, which typically supports the stock.

Market effects

Banking sector may see slight positive sentiment from a regional bank showing earnings growth and clean credit profile.

U.S. regional banking stocks could experience modest gains in the short term.

Limited to U.S. regional banking; no broader global impact.

Counterpoint

The profit increase may be temporary if loan growth slows or interest rates fall, limiting upside.

Key entities

  • Farmers & Merchants Bancshares

    U.S. regional bank (ticker FMFG) reporting earnings.

Related articles

$FMFGMed

FARMERS AND MERCHANTS BANCSHARES, INC. REPORTS EARNINGS OF $5.7 MILLION OR $1.76 PER SHARE FOR THE NINE MONTHS ENDED

Farmers & Merchants Bancshares, Inc. (FMFG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE FOR FURTHER INFORMATION CONTACT: October 22, 2026 Farmers and Merchants Bancshares, Inc. Contact: Mr. Gary A. Harris 4510 Lower Beckleysville Rd, Suite H President and Chief Executive Officer Hampstead, Maryland 21074 (410) 374-1510, ext. 1104 F

$FMFGMed

FARMERS AND MERCHANTS BANCSHARES, INC. REPORTS EARNINGS OF $3.7 MILLION OR $1.14 PER SHARE FOR THE SIX MONTHS ENDED

Farmers & Merchants Bancshares, Inc. (FMFG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_991668.htm EXHIBIT 99.1 ex_991668.htm Exhibit 99.1 FOR IMMEDIATE RELEASE FOR FURTHER INFORMATION CONTACT: July 23, 2026 Farmers and Merchants Bancshares, Inc. Contact: Mr. Gary A. Harris 4510 Lower Beckleysville Rd, Suite H President and Chief Executive Officer Hamps

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.